Effects of APOE4 allelic dosage on lipidomic signatures in the entorhinal cortex of aged mice
暂无分享,去创建一个
K. Duff | R. Chan | T. G. Oliveira | G. Di Paolo | E. Area-Gomez | Tal Nuriel | Archana Ashok | Bowen Zhou | A. M. Miranda | Yimeng Xu | Laura B Mcintire | A. Miranda
[1] G. Carter,et al. The APOEε3/ε4 Genotype Drives Distinct Gene Signatures in the Cortex of Young Mice , 2022, Frontiers in Aging Neuroscience.
[2] Takashi D. Y. Kozai,et al. Phospholipids of APOE lipoproteins activate microglia in an isoform-specific manner in preclinical models of Alzheimer’s disease , 2021, Nature Communications.
[3] William T. Ralvenius,et al. APOE4 disrupts intracellular lipid homeostasis in human iPSC-derived glia , 2021, Science Translational Medicine.
[4] D. Hilt,et al. A randomized single and multiple ascending dose study in healthy volunteers of LTI‐291, a centrally penetrant glucocerebrosidase activator , 2021, British journal of clinical pharmacology.
[5] Xiaojian Shi,et al. ApoE4 Impairs Neuron-Astrocyte Coupling of Fatty Acid Metabolism , 2021, Cell reports.
[6] Sheina Emrani,et al. APOE4 is associated with cognitive and pathological heterogeneity in patients with Alzheimer’s disease: a systematic review , 2020, Alzheimer's Research & Therapy.
[7] J. Smiley,et al. Endosomal Dysfunction Induced by Directly Overactivating Rab5 Recapitulates Prodromal and Neurodegenerative Features of Alzheimer's Disease. , 2020, Cell reports.
[8] M. Mann,et al. Cell-Type- and Brain-Region-Resolved Mouse Brain Lipidome. , 2020, Cell reports.
[9] Jie Zan,et al. Untargeted lipidomics reveals progression of early Alzheimer’s disease in APP/PS1 transgenic mice , 2020, Scientific Reports.
[10] D. Holtzman,et al. Regulation of beta-amyloid production in neurons by astrocyte-derived cholesterol , 2020, Proceedings of the National Academy of Sciences.
[11] G. Perea,et al. Sex-dependent calcium hyperactivity due to lysosomal-related dysfunction in astrocytes from APOE4 versus APOE3 gene targeted replacement mice , 2020, Molecular Neurodegeneration.
[12] A. Fagan,et al. APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline , 2020, Nature.
[13] M. Wenk,et al. Phospholipase D1 Ablation Disrupts Mouse Longitudinal Hippocampal Axis Organization and Functioning. , 2020, Cell reports.
[14] Y. Asmann,et al. Alzheimer’s Risk Factors Age, APOE Genotype, and Sex Drive Distinct Molecular Pathways , 2020, Neuron.
[15] Y. Asmann,et al. APOE4 exacerbates α-synuclein pathology and related toxicity independent of amyloid , 2020, Science Translational Medicine.
[16] Steve Lianoglou,et al. TREM2 Regulates Microglial Cholesterol Metabolism upon Chronic Phagocytic Challenge , 2019, Neuron.
[17] J. Gruenberg. Life in the lumen: The multivesicular endosome , 2019, Traffic.
[18] Xianlin Han,et al. APOE2 orchestrated differences in transcriptomic and lipidomic profiles of postmortem AD brain , 2019, Alzheimer's Research & Therapy.
[19] Jinsoo Seo,et al. ApoE4-Induced Cholesterol Dysregulation and Its Brain Cell Type-Specific Implications in the Pathogenesis of Alzheimer’s Disease , 2019, Molecules and cells.
[20] G. Bu,et al. Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies , 2019, Nature Reviews Neurology.
[21] D. Holtzman,et al. Cholesterol and matrisome pathways dysregulated in human APOE ε4 glia , 2019, bioRxiv.
[22] W. Annaert,et al. Endo-lysosomal dysregulations and late-onset Alzheimer’s disease: impact of genetic risk factors , 2019, Molecular Neurodegeneration.
[23] N. Sousa,et al. Differential lipid composition and regulation along the hippocampal longitudinal axis , 2019, Translational Psychiatry.
[24] Warren D. Smith,et al. The role of APOE4 in Alzheimer’s disease: strategies for future therapeutic interventions , 2019, Health psychology and behavioral medicine.
[25] D. Michaelson,et al. ApoE4: an emerging therapeutic target for Alzheimer’s disease , 2019, BMC Medicine.
[26] L. Goldstein,et al. Cholesterol Metabolism Is a Druggable Axis that Independently Regulates Tau and Amyloid-β in iPSC-Derived Alzheimer’s Disease Neurons , 2019, Cell stem cell.
[27] E. Fraenkel,et al. APOE4 is Associated with Differential Regional Vulnerability to Bioenergetic Deficits in Aged APOE Mice , 2018, Scientific Reports.
[28] P. Mathews,et al. Apolipoprotein E4 genotype compromises brain exosome production , 2018, Brain : a journal of neurology.
[29] Alexandre P. Blanchard,et al. Distinct disruptions in Land's cycle remodeling of glycerophosphocholines in murine cortex mark symptomatic onset and progression in two Alzheimer's disease mouse models , 2018, Journal of neurochemistry.
[30] T. Südhof,et al. Differential Signaling Mediated by ApoE2, ApoE3, and ApoE4 in Human Neurons Parallels Alzheimer’s Disease Risk , 2018, bioRxiv.
[31] Siegfried Kasper,et al. Spatial analysis and high resolution mapping of the human whole-brain transcriptome for integrative analysis in neuroimaging , 2018, NeuroImage.
[32] R. Rao,et al. Amyloid clearance defect in ApoE4 astrocytes is reversed by epigenetic correction of endosomal pH , 2018, Proceedings of the National Academy of Sciences.
[33] L. Tsai,et al. APOE4 Causes Widespread Molecular and Cellular Alterations Associated with Alzheimer’s Disease Phenotypes in Human iPSC-Derived Brain Cell Types , 2018, Neuron.
[34] P. Hiesinger,et al. Rab GTPases and Membrane Trafficking in Neurodegeneration , 2018, Current Biology.
[35] R. Chan,et al. Phospholipase D functional ablation has a protective effect in an Alzheimer’s disease Caenorhabditis elegans model , 2018, Scientific Reports.
[36] H. Riezman,et al. Understanding the diversity of membrane lipid composition , 2018, Nature Reviews Molecular Cell Biology.
[37] S. Small,et al. Neuronal lysosomal dysfunction releases exosomes harboring APP C-terminal fragments and unique lipid signatures , 2018, Nature Communications.
[38] M. Cookson,et al. The Endosomal–Lysosomal Pathway Is Dysregulated by APOE4 Expression in Vivo , 2017, Front. Neurosci..
[39] Yusuf A. Hannun,et al. Sphingolipids and their metabolism in physiology and disease , 2017, Nature Reviews Molecular Cell Biology.
[40] Geoffrey M. Barrett,et al. Neuronal hyperactivity due to loss of inhibitory tone in APOE4 mice lacking Alzheimer’s disease-like pathology , 2017, Nature Communications.
[41] Robert V Farese,et al. Lipid Droplet Biogenesis. , 2017, Annual review of cell and developmental biology.
[42] Irina Florina Tudorache,et al. Apolipoprotein E - A Multifunctional Protein with Implications in Various Pathologies as a Result of Its Structural Features , 2017, Computational and structural biotechnology journal.
[43] I. Lodhi,et al. Structural and functional roles of ether lipids , 2017, Protein & Cell.
[44] A. Gitler,et al. Defects in trafficking bridge Parkinson's disease pathology and genetics , 2016, Nature.
[45] D. Krainc,et al. Activation of β-Glucocerebrosidase Reduces Pathological α-Synuclein and Restores Lysosomal Function in Parkinson's Patient Midbrain Neurons , 2016, The Journal of Neuroscience.
[46] S. Gujja,et al. Cholesterol-Independent SREBP-1 Maturation Is Linked to ARF1 Inactivation. , 2016, Cell reports.
[47] E. Schon,et al. ApoE4 upregulates the activity of mitochondria‐associated ER membranes , 2015, EMBO reports.
[48] Bin Zhou,et al. Molecular Substrates of Schizophrenia: Homeostatic Signaling to Connectivity , 2015, Molecular Psychiatry.
[49] T. Eichmann,et al. DAG tales: the multiple faces of diacylglycerol—stereochemistry, metabolism, and signaling , 2015, Cellular and Molecular Life Sciences.
[50] S. Pääbo,et al. Organization and Evolution of Brain Lipidome Revealed by Large-Scale Analysis of Human, Chimpanzee, Macaque, and Mouse Tissues , 2015, Neuron.
[51] Arthur W. Toga,et al. Blood-Brain Barrier Breakdown in the Aging Human Hippocampus , 2015, Neuron.
[52] M. Plourde,et al. Fatty Acid Metabolism in Carriers of Apolipoprotein E Epsilon 4 Allele: Is It Contributing to Higher Risk of Cognitive Decline and Coronary Heart Disease? , 2014, Nutrients.
[53] F. Hsieh,et al. Di-22:6-bis(monoacylglycerol)phosphate: A clinical biomarker of drug-induced phospholipidosis for drug development and safety assessment. , 2014, Toxicology and applied pharmacology.
[54] Derick R. Peterson,et al. Plasma phospholipids identify antecedent memory impairment in older adults , 2014, Nature Medicine.
[55] E. Reiman,et al. Apolipoprotein E as a β-amyloid-independent factor in Alzheimer’s disease , 2013, Alzheimer's Research & Therapy.
[56] R. Martins,et al. Effects of a high-fat, high-cholesterol diet on brain lipid profiles in apolipoprotein E ɛ3 and ɛ4 knock-in mice , 2013, Neurobiology of Aging.
[57] S. Small,et al. Phosphatidylinositol-3-phosphate regulates sorting and processing of amyloid precursor protein through the endosomal system , 2013, Nature Communications.
[58] S. Niida,et al. Lipidomic analysis of brain tissues and plasma in a mouse model expressing mutated human amyloid precursor protein/tau for Alzheimer’s disease , 2013, Lipids in Health and Disease.
[59] Juan Antonio Vizcaíno,et al. Shorthand notation for lipid structures derived from mass spectrometry , 2013, Journal of Lipid Research.
[60] Daniel Weintraub,et al. APOE ε4 increases risk for dementia in pure synucleinopathies. , 2013, JAMA neurology.
[61] Berislav V. Zlokovic,et al. Apolipoprotein E controls cerebrovascular integrity via cyclophilin A , 2012, Nature.
[62] Markus R Wenk,et al. Comparative Lipidomic Analysis of Mouse and Human Brain with Alzheimer Disease* , 2011, The Journal of Biological Chemistry.
[63] G. Landreth,et al. Apolipoprotein E Promotes β-Amyloid Trafficking and Degradation by Modulating Microglial Cholesterol Levels* , 2011, The Journal of Biological Chemistry.
[64] Lothar Willmitzer,et al. Elemental formula annotation of polar and lipophilic metabolites using (13) C, (15) N and (34) S isotope labelling, in combination with high-resolution mass spectrometry. , 2011, The Plant journal : for cell and molecular biology.
[65] J. Wuu,et al. Upregulation of select rab GTPases in cholinergic basal forebrain neurons in mild cognitive impairment and Alzheimer's disease , 2011, Journal of Chemical Neuroanatomy.
[66] G. D. Paolo,et al. Linking lipids to Alzheimer's disease: cholesterol and beyond , 2011, Nature Reviews Cancer.
[67] David M Holtzman,et al. Human apoE Isoforms Differentially Regulate Brain Amyloid-β Peptide Clearance , 2011, Science Translational Medicine.
[68] C. Catania,et al. Stress Acts Cumulatively To Precipitate Alzheimer's Disease-Like Tau Pathology and Cognitive Deficits , 2011, The Journal of Neuroscience.
[69] G. D. Paolo,et al. Linking lipids to Alzheimer's disease: cholesterol and beyond , 2011, Nature Reviews Neuroscience.
[70] K. Wada,et al. Localization of MAP1-LC3 in Vulnerable Neurons and Lewy Bodies in Brains of Patients With Dementia With Lewy Bodies , 2011, Journal of neuropathology and experimental neurology.
[71] O. Arancio,et al. Phospholipase D2 Ablation Ameliorates Alzheimer's Disease-Linked Synaptic Dysfunction and Cognitive Deficits , 2010, The Journal of Neuroscience.
[72] R. Martins,et al. The effect of APOE genotype on brain levels of oxysterols in young and old human APOE ε2, ε3 and ε4 knock-in mice , 2010, Neuroscience.
[73] Yadong Huang,et al. Abeta-independent roles of apolipoprotein E4 in the pathogenesis of Alzheimer's disease. , 2010, Trends in molecular medicine.
[74] Tiago Gil Oliveira,et al. Phospholipase D in brain function and Alzheimer's disease. , 2010, Biochimica et biophysica acta.
[75] L. Mucke,et al. Phospholipase A2 reduction ameliorates cognitive deficits in a mouse model of Alzheimer's disease , 2008, Nature Neuroscience.
[76] A. Shevchenko,et al. Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics. , 2008, Journal of lipid research.
[77] P. Meikle,et al. Effect of lysosomal storage on bis(monoacylglycero)phosphate. , 2008, The Biochemical journal.
[78] A. Fagan,et al. Production and characterization of astrocyte-derived human apolipoprotein E isoforms from immortalized astrocytes and their interactions with amyloid-β , 2005, Neurobiology of Disease.
[79] D. Schmechel,et al. Marked regional differences of brain human apolipoprotein e expression in targeted replacement mice , 2004, Neuroscience.
[80] Matthew P. Frosch,et al. The ACAT Inhibitor CP-113,818 Markedly Reduces Amyloid Pathology in a Mouse Model of Alzheimer's Disease , 2004, Neuron.
[81] Xianlin Han,et al. The role of apolipoprotein E in lipid metabolism in the central nervous system , 2004, Cellular and Molecular Life Sciences.
[82] Xianlin Han,et al. Novel Role for Apolipoprotein E in the Central Nervous System , 2003, The Journal of Biological Chemistry.
[83] J. Touchon,et al. The Relationship between Apolipoprotein E4 and Lipid Metabolism Is Impaired in Alzheimer’s Disease , 2001, Gerontology.
[84] A. Fagan,et al. Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[85] A. Takeshita,et al. Altered cholesterol metabolism in human apolipoprotein E4 knock-in mice. , 2000, Human molecular genetics.
[86] S. Paul,et al. Lack of apolipoprotein E dramatically reduces amyloid β-peptide deposition , 1997, Nature Genetics.
[87] N. Maeda,et al. Targeted Replacement of the Mouse Apolipoprotein E Gene with the Common Human APOE3 Allele Enhances Diet-induced Hypercholesterolemia and Atherosclerosis* , 1997, The Journal of Biological Chemistry.
[88] T. Wisniewski,et al. Fibrillogenesis in Alzheimer's disease of amyloid beta peptides and apolipoprotein E. , 1995, The Biochemical journal.
[89] H. Brewer,et al. Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments , 1994, Nature.
[90] A D Roses,et al. Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[91] B. Hyman,et al. Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions , 1993, Neuron.
[92] Hana L. Goldschmidt,et al. Diacylglycerol, phosphatidic acid, and their metabolic enzymes in synaptic vesicle recycling. , 2015, Advances in biological regulation.
[93] D. Michaelson,et al. The isoform-specific pathological effects of apoE4 in vivo are prevented by a fish oil (DHA) diet and are modified by cholesterol. , 2012, Journal of Alzheimer's disease : JAD.
[94] J. Buxbaum,et al. Profiling brain and plasma lipids in human APOE epsilon2, epsilon3, and epsilon4 knock-in mice using electrospray ionization mass spectrometry. , 2010, Journal of Alzheimer's disease : JAD.
[95] A. Fagan,et al. Production and characterization of astrocyte-derived human apolipoprotein E isoforms from immortalized astrocytes and their interactions with amyloid-beta. , 2005, Neurobiology of disease.
[96] H. Braak,et al. Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.
[97] R. Mahley,et al. Apolipoprotein E: far more than a lipid transport protein. , 2000, Annual review of genomics and human genetics.
[98] S. Paul,et al. Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition. , 1997, Nature genetics.
[99] J. Ma,et al. Amyloid-associated proteins alpha 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer beta-protein into filaments. , 1994, Nature.